Pain relieving effect of Ayurvedic drugs Amritbhallataka and Navjeevan Rasa in sciatica patients

A comparative study to evaluate the efficacy of Amritbhallataka and Navjeevan rasa in disintegration of pathogenesis in Gridhrasi patients- Randomized clinical trial. - NIL

Status

Active, not recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/05/066880

Enrollment

Registered

2024-05-07

Start date

Unknown

Completion date

Unknown

Last updated

2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M511- Thoracic, thoracolumbar and lumbosacral intervertebral disc disorders with radiculopathy

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients having classical symptoms of Gridhrasi as described in the Ayurvedic literature.

Exclusion criteria

Exclusion criteria: 1. Pitta Prakriti patients. 2. Pregnant women and lactating mothers

Design outcomes

Primary

Measure	Time frame
The therapeutic effect of Amritbhallatak and Navjeevan rasa in Gridharsi patients.Timepoint: Day 0, Day 15, Day 30	—

Secondary

Measure	Time frame
The study will provide cost effective, safe ayurvedic drug with minimal or no side effects in Gridharsi patients.Timepoint: 30 days	—

Countries

India

Contacts

Public ContactDr Thabiram Majhi

Chaudhary Brahm Prakash Ayurved Charak Sansthan,New Delhi

thabirambulu@gmail.com8018452897

Outcome results